Cite
Halfon P, Imbert-Bismut F, Messous D, et al. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comp Hepatol. 2002;1(1):3doi: 10.1186/1476-5926-1-3.
Halfon, P., Imbert-Bismut, F., Messous, D., Antoniotti, G., Benchetrit, D., Cart-Lamy, P., Delaporte, G., Doutheau, D., Klump, T., Sala, M., Thibaud, D., Trepo, E., Thabut, D., Myers, R. P., & Poynard, T. (2002). A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comparative hepatology, 1(1), 3. https://doi.org/10.1186/1476-5926-1-3
Halfon, Philippe, et al. "A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease." Comparative hepatology vol. 1,1 (2002): 3. doi: https://doi.org/10.1186/1476-5926-1-3
Halfon P, Imbert-Bismut F, Messous D, Antoniotti G, Benchetrit D, Cart-Lamy P, Delaporte G, Doutheau D, Klump T, Sala M, Thibaud D, Trepo E, Thabut D, Myers RP, Poynard T. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comp Hepatol. 2002 Dec 30;1(1):3. doi: 10.1186/1476-5926-1-3. PMID: 12537583; PMCID: PMC149429.
Copy
Download .nbib